Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651055.RAWI707s-wJCIlTPt7OU7g2EXVfhR9ReEXfAZMZARp_sw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651055.RAWI707s-wJCIlTPt7OU7g2EXVfhR9ReEXfAZMZARp_sw130_assertion type Assertion NP651055.RAWI707s-wJCIlTPt7OU7g2EXVfhR9ReEXfAZMZARp_sw130_head.
- NP651055.RAWI707s-wJCIlTPt7OU7g2EXVfhR9ReEXfAZMZARp_sw130_assertion description "[The CPA/P450 prodrug activation system may thus serve as a useful paradigm for further development of novel cancer gene therapy strategies that utilize drug susceptibility genes to significantly potentiate the antitumor activity of conventional cancer chemotherapeutic agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651055.RAWI707s-wJCIlTPt7OU7g2EXVfhR9ReEXfAZMZARp_sw130_provenance.
- NP651055.RAWI707s-wJCIlTPt7OU7g2EXVfhR9ReEXfAZMZARp_sw130_assertion evidence source_evidence_literature NP651055.RAWI707s-wJCIlTPt7OU7g2EXVfhR9ReEXfAZMZARp_sw130_provenance.
- NP651055.RAWI707s-wJCIlTPt7OU7g2EXVfhR9ReEXfAZMZARp_sw130_assertion SIO_000772 8640822 NP651055.RAWI707s-wJCIlTPt7OU7g2EXVfhR9ReEXfAZMZARp_sw130_provenance.
- NP651055.RAWI707s-wJCIlTPt7OU7g2EXVfhR9ReEXfAZMZARp_sw130_assertion wasDerivedFrom befree-20140225 NP651055.RAWI707s-wJCIlTPt7OU7g2EXVfhR9ReEXfAZMZARp_sw130_provenance.
- NP651055.RAWI707s-wJCIlTPt7OU7g2EXVfhR9ReEXfAZMZARp_sw130_assertion wasGeneratedBy ECO_0000203 NP651055.RAWI707s-wJCIlTPt7OU7g2EXVfhR9ReEXfAZMZARp_sw130_provenance.